Cardiovascular
Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
- Acute Phase Reactants(17)
- Angina(14)
- Arrhythmia(85)
- Atherosclerosis(93)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(46)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(131)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(10)
- Endothelium(35)
- Erythrocytes & Hemoglobin(53)
- Heart Failure(32)
- Hypertension(167)
- Hypotension(24)
- Lipoproteins(66)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(64)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(37)
- Storage & Transport(6)
- Stroke(53)
- Vasoconstriction(61)
- Thrombosis(58)
- Vasodilation(146)
Cardiovascular 相关产品(860)
- GC49884Trigonelline-d3 (chloride)纯度: >99.00%
An internal standard for the quantification of trigonelline
- GC49890β-Glycerophosphate-d5 (sodium salt hydrate)纯度: >99.00%
An internal standard for the quantification of β-glycerophosphate
- GC49916Lys-(Des-Arg9, Leu8)-Bradykinin (trifluoroacetate salt)纯度: >95.00%
A bradykinin B 1 receptor antagonist
- GC50009LY 294002 hydrochlorideCAS: 934389-88-5纯度: >98.00%
Prototypical PI 3-kinase inhibitor; also inhibits other kinases
- GC50196Simvastatin - d6CAS: 1002347-71-8纯度: >99.50%
An internal standard for the quantificaition of simvastatin
- GC52023Alfuzosin-d7CAS: 1133386-93-2纯度: >99.00%
An internal standard for the quantification of alfuzosin
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC49784 | AZD 2716 | 1845753-81-2 | >98.00% | |
An sPLA 2 inhibitor | ||||
| GC49812 | Urobilin (hydrochloride) | 28925-89-5 | 不显示 | |
A byproduct of hemoglobin degradation | ||||
| GC49836 | Benoxaprofen | 51234-28-7 | >98.00% | |
An NSAID | ||||
| GC49842 | Digoxigenin Bisdigitoxoside | 5297-05-2 | >98.00% | |
A Na + /K + -ATPase inhibitor | ||||
| GC49863 | Cytarabine 5′-monophosphate | 7075-11-8 | >95.00% | |
An active metabolite of cytarabine | ||||
| GC49866 | Desmethyl Carvedilol | 72956-44-6 | >90.00% | |
An active metabolite of carvedilol | ||||
| GC49873 | Protectin D1 methyl ester | 934005-36-4 | >95.00% | |
An esterified form of protectin D1 | ||||
| GC49880 | Bradykinin (trifluoroacetate salt) | - | >95.00% | |
An endogenous vasodilator | ||||
| GC49882 | Hemokinin 1 (human) (trifluoroacetate salt) | - | >98.00% | |
A peptide agonist of NK 1 receptors | ||||
| GC49884 | Trigonelline-d3 (chloride) | - | >99.00% | |
An internal standard for the quantification of trigonelline | ||||
| GC49885 | BQ-3020 (trifluoroacetate salt) | - | >90.00% | |
A peptide ET B receptor antagonist | ||||
| GC49890 | β-Glycerophosphate-d5 (sodium salt hydrate) | - | >99.00% | |
An internal standard for the quantification of β-glycerophosphate | ||||
| GC49916 | Lys-(Des-Arg9, Leu8)-Bradykinin (trifluoroacetate salt) | - | >95.00% | |
A bradykinin B 1 receptor antagonist | ||||
| GC50009 | LY 294002 hydrochloride | 934389-88-5 | >98.00% | |
Prototypical PI 3-kinase inhibitor; also inhibits other kinases | ||||
| GC50196 | Simvastatin - d6 | 1002347-71-8 | >99.50% | |
An internal standard for the quantificaition of simvastatin | ||||
| GC52005 | Triazolomethylindole-3-acetic Acid | 177270-91-6 | >95.00% | |
A metabolite of rizatriptan | ||||
| GC52006 | CB-096 | 108883-90-5 | >98.00% | |
An inhibitor of RAN translation | ||||
| GC52007 | N-hydroxylamine Dapsone | 32695-27-5 | >98.00% | |
An active metabolite of dapsone | ||||
| GC52011 | Stearic Acid glycidyl ester | 7460-84-6 | >95.00% | |
An esterified form of stearic acid | ||||
| GC52019 | Norpropranolol (hydrochloride) | 62618-09-1 | >98.00% | |
An active metabolite of propranolol | ||||
| GC52023 | Alfuzosin-d7 | 1133386-93-2 | >99.00% | |
An internal standard for the quantification of alfuzosin | ||||
| GC52034 | Quinaprilat | 82768-85-2 | >90.00% | |
An ACE inhibitor and active metabolite of quinapril | ||||
| GC52035 | Esmolol Acid (hydrochloride) | 83356-60-9 | >98.00% | |
An active metabolite of esmolol | ||||
| GC52045 | N-desmethyl Azelastine | 47491-38-3 | >98.00% | |
An active metabolite of azelastine | ||||